Andrew Jacobs
Posts
FDA Issues Warning Over Misuse of Ketamine Therapy
Unsupervised treatment — fueled by telemedicine prescriptions — for various psychiatric problems poses a number of health risks, the agency said.
Soy, Oat and Almond Drinks Can be Called Milk: FDA
Plant-based beverage makers hailed the agency’s decision but objected to the recommendation for labels to specify the nutritional differences with cow’s milk.
FDA Seeks More Authority to Oversee CBD Products
The agency wants Congress to intervene, saying it does not have adequate oversight powers to ensure the safety of the myriad cannabidiol products derived from...
Legal Use of Hallucinogenic Mushrooms Begins in Oregon
On Jan. 1, Oregon became the first state to allow adult use of psilocybin “magic” mushrooms. Licensed guides will likely determine whether the program is...
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.
Hemp-Fed Cows Get Buzzed, Study Finds, but Will Humans Who Drink Their Milk?
Hemp with high THC content given to Holsteins leached into their milk, according to a group of German scientists exploring the food chain for dairy...
WHO Lists Top Fungi Health Threats
The pathogens cause infections that kill millions of people each year and often go undiagnosed. Even when identified, a growing number of infections is resistant...
With Promise of Legalization, Psychedelic Companies Joust Over Future Profits
Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies...
Animal Rights Activists Await Verdict in Smithfield Piglet Case
The Utah trial has highlighted what the defendants argue is a lack of transparency for the treatment of animals at large corporate farms.
Samples of Popular Diabetes Drug Contain Potential Carcinogen, F.D.A. Says
Testing found nitrosamine contamination in some samples of Januvia, but regulators will allow Merck to continue selling the drug for now.